Official Journals By StatPerson Publication

 

REFERENCES

  1. Innes JA, Reid PT. Respiratory disease: Chronic ObstructivePulmonary Disease (COPD). In Boon NA, College NR, Walker BR, Hunter JAA, editors. Davidson’s Principles and Practice of Medicine, (20th Ed). Edinburg: ChurchillLivingstone Elsevier 2006; 678-84.
  2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Executive summary. Medical Communications Resources, Inc 2007; 1-43.
  3. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nature Med 1998; 4: 1241-3.
  4. Reilly JJ, Silverman EK, Shapiro SD. Chronic obstructive pulmonary disease. In Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harrison’s Principles of Internal Medicine (16th Ed.) New York: McGraw-Hill Medical Publishing Division 2005; 1547-54.
  5. Schmailzl KJG. Conventional Echocardiography: Examination Procedure, Fundamental measurement and Assessment Tasks. In Schmailzl JG, Ormerod O, Editors. Ultrasound in Cardiology (1st Ed.). Berlin: Blackwell Science 1994; 49-8.
  6.  Oh JK, Seward JB, Tajik AJ. The Echo Manual: the Mayo Clinic (13rd Ed.). New Delhi: Lippincott Williams 2006; 7-28.
  7. Rich S, McLaughlin VV. Pulmonary Hypertension Associated with Disorders of the Respiratory System: Chronic Obstructive Pulmonary Disease In Zipes DB, Libby P, BonowRO, Braunwald E , editors. Braunwald’s Heart Disease: Atextbook of cardiovascular medicine (7th Ed) Philadelphia: Elsevier Saunders 2005: 1831-5.
  8. Weitzenblum E, Hirth C, Ducolonea et al. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 1981; 36: 752-8.
  9. Siafakas NM, Vermeire P, Pride NB et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force.EurRespir1995; 8: 1398-420.
  10. Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic corpulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1: 681-6.
  11. Nocturnal Oxygen Therapy Trial Group. Continuous ornocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980; 93: 391-8.
  12. Weitzenblum E, Sautegeau A, Ehrhart M et al. Long-termoxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonarydisease. Am Rev Respir Dis 1985; 131: 493-8.
  13. Packer M, Bristow MR, Cohn JN et al. The effect of carvedilolon morbidity and mortality in patients with chronic heartfailure. N Engl J Med 1996; 334: 1349-55.
  14. Packer M, Coats AJS, Fowler MB et al. The effect ofcarvedilol on the survivial in severe chronic heart failure. NewEngl J Med 2001; 344: 1651-8.
  15. MERIT-HT Study Group. Effect of metoprolol CR/XL inchronic heart failure: Metoprolol CR/XL RandomisedIntervention Trial in congestive heart failure (MERIT-HF).Lancet 1999; 353: 2001-7.
  16. CIBIS II Investigators and Committees. The CardiacInsufficiency Bisoprolol Study II (CIBIS II): a randomizedtrial. Lancet 1999; 353: 9-13.
  17. Poole-Wilson PA, Swedberg K, Cleland JGF et al. Comparison of carvedilol and metoprolol on clinicaloutcomes in patients with chronic heart failure in theCarvedilolor Metoprolol European Trial (COMET): randomized controlled trial. Lancet 2003; 362: 7-13.
  18. Remme WJ, Cleland JG., Di Lenarda A et al. Carvedilol betterprotects against vascular events than metoprolol in heartfailure: results from COMET. J AmerCollCardiol 2007; 49: 96371.
  19. Jenkins CR, Chow CM, Fisher BL, Marlin GE. Comparisonof ipratropium bromide and salbutamol by aerosolizedsolution. Aust N Z J Med 1981; 11: 513-6.
  20. Jarvis b, Markham A. Inhaled salmeterol: a review of itsefficacy in chronic obstructive pulmonary disease. Drugs Aging 2001; 18: 441-72.
  21.  Cheer SM, Scott LJ. Formoterol: a review of its use in chronicobstructive pulmonary disease. Amer J RespirMed2006; 1: 285-300.
  22. Brown IG, Chan CS, Kelly CA, Dent Ag, Zimmerman PV. Assessment of the clinical usefulness of nebulised ipratropiumbromide in patients with chronic airflow limitation. Thorax1984; 39: 272-6.
  23. Keam SJ, Keating GM. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD TreatRespir Med 2004; 3: 247-68.
  24. Soriano JB, Kiri VA, Pride NB, Vestbo J. Inhaledcorticosteroids with/ without long-acting beta-agonists reducethe risk of rehospitalization and death in COPD patients. AmerJ Respir Med 2003; 2: 67-74.
  25. Khan MG. Cardiac drug therapy: Beta-Blockers: The Cornerstone of Cardiac Drug Therapy. 6th ed. USA: Saunders 2003; 1-52.
  26. Germann P, Ziesche R, Leitner C et al. Addition of nitricoxygen to oxygen improves cardiopulmonary function inpatients with severe COPD. Chest 1998; 114: 29-35.
  27. Yashida M, Taguchi O, Gabazza EC et al. Combinedinhalation of nitric oxide and oxygen in chronic obstructivepulmonary disease. Amer J RespirCrit Care Med1997; 155: 526-9.
  28. Katayama Y, Higenbottam TW, Diaz de Atauri MJ et al.Inhaled nitric oxide and arterial tension in patients withchronic obstructive pulmonary disease and severe pulmonaryhypertension. Thorax 1997; 52: 120-4.
  29. Vonbank K, Ziesche R, Higenbottam TW et al. controlledprospective randomized trial on the effects on pulmonaryhaemodynamics of the ambulatory long term use of nitricoxide and oxygen in patients with severe COPD.Thorax2003; 58: 289-93.Limthongkul S, Wongthim S, Udompanich V, Charoenlap P,Nuchprayoon CJ. Mechanical and non-mechanical ventilationof respiratory failure in chronic obstructive pulmonarydisease. J Med Assoc Thai 1993; 76: 1-8.
  30. Vitacca M, Clini E, Rubini F, Nava S, Foglio K, Ambrosino N.Non-invasive mechanical ventilation in severe chronicobstructive lung disease and acute respiratory failure: shortand Long-term prognosis. Intensive Care Med 1996; 22: 94-100.
  31. Vitacca M, Rubini F, Foglio K, Scalvini S, Nava S, AmbrosinoN. Non-invasive modalities of positive pressure ventilationimproves the outcome of acute exacerbations in COLD Patients. Intensive Care Med 1993; 19: 450-5.
  32. Arcasoy SM, Christie JD, Ferrari VA et al. Echocardiographicassessment of pulmonary hypertension in patients with advancedlung disease. Amer J RespirCrit Care Med 2003; 167: 735.0.

 

STATPERSON PUBLISHING GROUP | Aurangabad | Maharashtra |2016 | INDIA
© Copyright 2016 Statperson Publishing Corporation. a division of Statperson Consultancy.
All Rights Reserved.